Introduction {#sec1}
============

Embryos are complex systems whose development depends on the intricate, time-dependent interplay between very large numbers of circuits operating at the molecular, cellular, organ, and whole organism level ([@ref14]; [@ref276]). Collectively, these circuits control the emergent properties of the system, which include key features of normal development: cell differentiation, proliferation, movement, and communication. For example, cell differentiation depends, in part, on molecular circuitry controlling genome-wide expression patterns, which both promote cell-lineage commitment, and where appropriate, maintain cell identity ([@ref189]; [@ref186]; [@ref83]; [@ref139]).

Much has been learnt about mammalian embryos by studying them *in vivo* or isolating them at specific stages of development ([@ref18]; [@ref68]; [@ref140]; [@ref122]). *In vivo*, all of the correct signals for normal development are available and to some extent can be manipulated (e.g., by altering maternal diet or applying drugs). The use of transgenic, knockout, and knock-in animals has greatly assisted in understanding key regulatory mechanisms of developmental processes ([@ref18]; [@ref9]; [@ref163]; [@ref68]; [@ref86]; [@ref102]). Nevertheless, there are, at present, restrictions to *in vivo* studies, which include: (1) the relative inaccessibility of the mammalian embryo and the difficulty in observing it in real time ([@ref111]); (2) the difficulty in manipulating the embryo in the face of maternal control and that of the embryo itself; and (3) many critical steps in development are fleeting and involve a very small number of cells ([@ref12]; [@ref57]; [@ref26]; [@ref31]; [@ref76]; [@ref3]).

For these and other reasons, pluripotent stem cells such embryonic stem cells (ESCs), epiblast-derived stem cells (EpiSCs), and induced pluripotent stem cells (iPSCs) have been used as facile *in vitro* models of *in vivo* mammalian (including human) development ([@ref67]; [@ref153]; [@ref248]; [@ref247]; [@ref253]). Cultured pluripotent stem cells have the capacity to undergo differentiation into all three germ layers, and subsequent elaboration into all of the cells of the developing embryo and adult, including most extraembryonic cell types.

Importantly, cultured pluripotent stem cells can be directed down selected lineages by careful control of the culture environment including, for example, the addition and removal of exogenous factors, altering the concentration of those factors, control of oxygen concentration and cell density, and the removal of waste products ([@ref266]). Under favorable circumstances, a series of near-homogeneous cell populations can be produced, which mimic the ontogenetic series observed in development ([@ref203]; [@ref292]; [@ref92]; [@ref170]).

The advantage, then, in using pluripotent stem cells for lineage studies is that selected aspects of development can be analyzed: Cell types, generally, can be readily identified (e.g., through marker and/or functional analysis), the molecular mechanisms at play can be identified, and the contribution of the molecular mechanisms to emergent properties of the system such as differentiation, changes in proliferation and apoptosis, and changes in morphology, motility, and functional capacity can be quantified.

In more recent years, mathematical modeling of large data sets (e.g., micro- and kinome arrays, DNA methylation and histone modification analyses, and transcriptome analyses using RNAseq on groups of cells or single cells) has provided insight into the complex nature of molecular control in development ([@ref121]; [@ref126]; [@ref194]). This modeling is helping to uncover, for example, key gene circuitry, signaling pathway crosstalk, as well as important nonlinear interactions between the various layers of regulatory control within and between cells ([@ref148]; [@ref150]; [@ref99]). These advances are bringing us closer to understanding the laws that govern the self-organizing properties of biological systems ([@ref14]; [@ref198]) and how the disruption of critical circuitry can compromise normal development.

Our understanding of embryonic development has increased significantly since the isolation of mouse ESCs in 1981 ([@ref67]), but much is still unknown about the induction of the nervous system during which the multipotent germ layer of definitive ectoderm commits to form neurectoderm. Instead, attention has focused on generating more mature neural cells directly from mammalian ESCs or from endogenous neural stem cells cultured *ex vivo* ([@ref34]; [@ref141]; [@ref187]). Part 1 of this review will address our current understanding of the *in vivo* molecular mechanisms driving development up to and including the commitment to neurectoderm, using the mouse as a model organism, while Part 2 will address these aspects using pluripotent stem cells as an *in vitro* model for embryonic development. Part 3 will then focus on the important role that amino acids play in this process both *in vivo* and *in vitro.*

Mouse Pre- and Post-Implantation Embryogenesis {#sec2}
==============================================

Formation of the Egg-Cylinder {#sec3}
-----------------------------

Following fertilization of the oocyte, the resulting zygote undergoes a series of cell divisions, such that at 2--3 days post coitum (dpc) the embryo consists of 8--16 identical blastomeres ([@ref144]; [@ref171]). Each blastomere is totipotent and expresses genetic markers of the future pluripotent inner cell mass (ICM) (e.g., *Oct4, Nanog* and *Rex1*) as well as extraembryonic lineages (e.g., *Gata6* and *Sox17*) ([Figure 1](#fig1){ref-type="fig"}; [@ref156]; [@ref260]; [@ref115]; [@ref173]; [@ref270]). These cells, therefore, maintain the ability to differentiate into all of the embryonic and extraembryonic cells that contribute to the development of the embryo. By 3.0 dpc, the embryo compacts to form the morula, resulting in the formation of E-cadherin-mediated adherens junctions between the outer blastomeres, and establishing the first apical-basal polarization of the embryo ([@ref2]). The outer and inner cells are now destined for different fates.

![Early pre- and post-implantation mouse embryonic development until the egg cylinder stage. (A) Following fertilization, the embryo undergoes a series of cleavage divisions as it travels down the fallopian tube. Between 3.5 and 4.5 dpc, the embryo, now known as a blastocyst, consists of two cell populations: An outer multipotent trophectoderm (TE) (expressing *Cdx2*), and a mosaic inner pluripotent inner cell mass (ICM) population. At 4.0 dpc, the blastocyst hatches from the *zona pelucida* and implants into the uterine wall. **(B)** Cells of the 4.0 dpc ICM expressing *Gata6* and *Sox17* move to line the blastocoelic cavity, lose pluripotency, and differentiate into the extraembryonic primitive endoderm (or hypoblast) by 4.5 dpc. Together the remaining cells of the ICM (the epiblast) and the hypoblast form the bilaminar disc by 5.0 dpc. At this stage, cells of the pluripotent epiblast that have not moved to be in contact with the extracellular matrix laid down between the hypoblast undergo apoptosis to help form the proamniotic cavity. Hypoblast cells that remain in close contact with the epiblast differentiate into visceral endoderm (VE) while those that migrate along the basement membrane of the TE form the *tPA^+^* parietal endoderm (PaE), resulting in the formation of the yolk sac. At 5.5 dpc the embryo is known as the egg cylinder. The remaining surviving epiblast cells have differentiated into a second pluripotent population of pseudo-stratified cells known as the primitive ectoderm (PrEct). The TE differentiates into cells that constitute the placenta including the extraembryonic endoderm (EXE).](fphys-10-00705-g001){#fig1}

The upregulation of ion pumps and exchangers in the outer blastomeres accompanies compaction and allows the transport of ions including Na^+^ and Cl^−^, followed by the passive diffusion of water, into the center of the embryo ([@ref16]). Thus, by 3.5 dpc, the blastocoelic cavity has formed ([@ref275]) and the embryo, now known as a blastocyst, consists of an outer multipotent *Cdx2^+^* trophectoderm population, and the pluripotent ICM attached underneath the polar trophectoderm ([Figure 1](#fig1){ref-type="fig"}). In keeping with these changes in cell fate, the trophectoderm downregulates expression of the pluripotency marker *Oct4* while maintaining the expression of *Cdx2*, restricting these cells to the placental lineage. In contrast, the ICM downregulates *Cdx2*, and in addition, some cells maintain the expression of *Nanog* and *Rex1* while others express *Gata6* and *Sox17* to produce a mosaic "salt-and-pepper" pattern of cells across the ICM ([@ref188]; [@ref44]; [@ref260]; [@ref8]). *Oct4* continues to be expressed in all the cells of the ICM at this stage, indicating maintenance of pluripotency ([Figure 1](#fig1){ref-type="fig"}; [@ref44]).

Just prior to the blastocyst hatching from the *zona pellucida* (4.0 dpc) two distinct cell lineages form within the ICM: a combination of actin-dependent cell-sorting and positional induction promotes movement of the *Gata6^+^/Sox17^+^* cells such that they line the blastocoel ([Figure 1](#fig1){ref-type="fig"}; [@ref157]; [@ref8]). This monolayer is known as the extraembryonic primitive endoderm (or hypoblast), and in keeping with its loss of pluripotency switches off expression of pluripotency markers such as *Oct4*. Primitive endoderm and its successor, the *Hnf4^+^* visceral endoderm (VE) ([@ref63]), lay down an extracellular matrix (ECM) that separates it from the remaining ICM ([@ref44]; [@ref173]; [@ref270]). The ICM now consists of a *Nanog^+^/Oct4^+^* population, known as the naïve epiblast and can give rise to all somatic and germline cells ([@ref174]). At this stage, the naïve epiblast is squeezed between its multipotent neighbors: the *Gata6^+^/Sox17^+^/Oct4^−^* hypoblast and *Cdx2^+^/Oct4^−^* polar trophectoderm ([Figure 1](#fig1){ref-type="fig"}; [@ref241]; [@ref175]; [@ref8]).

Shortly after implantation (4.5 dpc), the naïve epiblast undergoes epithelialization and subsequent cavitation to form the proamniotic cavity. This occurs as a result of the secretion of the negatively charged anti-adhesive sialomucin protein, Podx1, on the apical surface of the hypoblast ([@ref810]). As the expression of naïve pluripotency genes (such as *Nanog*) are downregulated, Podx1 expression and secretion increases, resulting in the inability of epiblast cells to make connections with one another ([@ref810]). When *Podx1* expression is inhibited in \~4.5 dpc mouse embryos cultured in conditions that maintain pluripotency, proamniotic cavity formation is blocked ([@ref810]). Failure to cavitate results in embryonic lethality at \~5.5 dpc ([@ref229]).

The remaining epiblast cells now undergo a transition to a second pluripotent population of pseudostratified columnar epithelium known as primitive ectoderm \[also referred to as the primed epiblast ([@ref175])\] ([@ref188]). The transition includes an increased rate of proliferation and expands the pluripotent cell pool from \~120 cells at 5.5 dpc to \~660 by 6.5 dpc ([@ref230]), preparing the embryo for gastrulation. During this time, the cell cycle reduces from \~12 h to as little as 4.4 h ([@ref230]). The expression of pluripotency markers such as *Oct4* is maintained, ICM markers such as *Rex1* ([@ref188]) are downregulated ([@ref262]) and primitive ectoderm markers such as *Fgf5* are upregulated ([@ref94]; [@ref96]; [@ref188]; [@ref117]).

The embryo has now taken the form of a cup shape known as the egg cylinder ([Figure 1](#fig1){ref-type="fig"}; [@ref7]; [@ref174]). The pluripotent primitive ectoderm is primed for gastrulation and will give rise to the three multipotent germ layers of the embryo *proper* ([@ref188]). Concurrently, the polar trophectoderm proliferates and differentiates into the extraembryonic ectoderm (EXE) and the ectoplacental cone in response to Fgf4 signaling from the underlying pluripotent cells ([@ref84]; [@ref79]). This extraembryonic tissue differentiates into support structures, including the placenta.

Gastrulation and the Formation of the Three Germ Layers {#sec4}
-------------------------------------------------------

Shortly after implantation, the pluripotent primitive ectoderm gastrulates to form the three multipotent germ layers of endoderm, mesoderm, and ectoderm. This process, known as gastrulation, begins in the mouse at 6.5 dpc ([@ref286]; [@ref171]; [@ref207]) with the formation of the primitive streak on the posterior side of the embryo. The streak reaches its final length by \~7.5 dpc ([@ref279]).

During gastrulation, some primitive ectoderm cells undergo an epithelial-to-mesenchyme transition (EMT). They ingress the streak and emerge as cells of the mesoderm and endoderm germ layers ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}; [@ref144]; [@ref7]) depending on the time and place in the streak through which they migrate.

![Formation of the primitive body plan following gastrulation in the mouse. (A) Right hand panel: Pro-Nodal secreted from the extraembryonic ectoderm (EXE) is converted to Nodal in the presence of the convertases Furin (F) and Pace4 (P). Nodal acts on the visceral endoderm (light green cells) to regulate the expression of pro-Nodal and production of Nodal. A feedback system is established between Nodal, BMP and Wnt3 causing primitive ectoderm (PrEct) cells on the posterior side to ingress through the primitive streak, which continues to elongate in a proximal-distal direction from 6.5 dpc. Cells that migrate through the primitive streak form the definitive mesoderm (ME) and endoderm (DEnd) germ layers. Left hand panel: On the anterior side of the embryo, the anterior visceral endoderm (AVE; dark green cells) secretes the Nodal antagonists Cer1 and Lef1, and the Wnt3 antagonist Dkk1, inhibiting Nodal and Wnt3 signaling and thus establishing the definitive ectoderm germ layer by 7.0 dpc. BMP4 is secreted from the EXE, while BMP4 antagonists including Noggin (Ngn), Chordin (Chd) and Follistatin (Fsn) are secreted from the Node (N), establishing a gradient of BMP4 across the definitive ectoderm, such that by **(B)** 7.5 dpc, BMP4-mediated SMAD signaling in the proximal definitive ectoderm produces surface ectoderm (SE) while the distal definitive ectoderm differentiates to neurectoderm (NE) in the absence of SMAD signaling. **(C)** Following the completion of gastrulation at \~7.5 dpc, the ME differentiates to give rise to the paraxial mesoderm (pME) and lateral plate mesoderm (lpME), the DEnd produces the gut tube (GT) and the NE gives rise to the neural tube (NT). Additional key: EXM/En, extraembryonic mesoderm/endoderm; Prox, proximal; Dist, distal; A, anterior; P, posterior.](fphys-10-00705-g002){#fig2}

![Gastrulation gives rise to the three primary germ layers of the embryo *proper.* The inner cell mass (ICM) is a pluripotent population of cells that arises between 3.5 and 4.5 dpc within the blastocyst. By 5.5 dpc, the ICM differentiates into the multipotent extraembryonic primitive endoderm lineage and a second pluripotent population, the primitive ectoderm. At 6.5 dpc, the primitive ectoderm undergoes gastrulation in response to various signals including Nodal, resulting in a subset of cells undergoing an epithelial-to-mesenchymal transition (EMT), allowing them to ingress through the primitive streak and form the definitive mesoderm and definitive endoderm germ layers. The remaining primitive ectoderm cells (which see little or no Nodal) do not move through the streak and give rise to the definitive ectoderm germ layer, which further differentiates into the surface ectoderm and neurectoderm in response to the presence and absence of BMP4 signaling, respectively. Key: CNS, central nervous system; ENS, enteric nervous system; GIT, gastrointestinal tract (epithelial lining); PNS, peripheral nervous system; RT, respiratory tract (epithelial lining).](fphys-10-00705-g003){#fig3}

The fate of these cells depends on the carefully orchestrated actions of three secreted growth factors, Nodal, Wnt3, and BMP4, from the surrounding tissues ([Figure 2](#fig2){ref-type="fig"}; [@ref207]; [@ref249]; [@ref7]).

Nodal is a member of transforming growth factor-β (TGF-β) superfamily. In its mature form, Nodal binds to and activates cell-surface activin-like kinase (ALK) receptor complexes (ActR-I/ActR-II) resulting in SMAD2/3-regulated modulation of gene expression. The stability of Nodal is compromised following cleavage, restricting its ability to diffuse and therefore signal over long distances ([@ref218]; [@ref134]).

Nodal is secreted by VE and acts on VE and surrounding EXE as early as \~5.5 dpc to promote its own expression ([Figure 2](#fig2){ref-type="fig"}; [@ref134]). By \~6.0 dpc, Nodal expression is restricted to the posterior side of the primitive ectoderm, where it assists in the induction of the primitive streak ([Figure 2](#fig2){ref-type="fig"}; [@ref221]) by stimulating the expression of streak genes including *Mixl1* and *Goosecoid (Gsc)* ([@ref288]; [@ref107]). Following this, Nodal signaling is also essential for mesendoderm specification of pluripotent cells moving through the streak ([@ref19]; [@ref221]).

Pro-Nodal, though immature, also has biological activity and acts on the EXE to induce the expression of BMP4, which in turn causes EXE to secrete Wnt3 ([Figure 2](#fig2){ref-type="fig"}; [@ref17]; [@ref134]). Wnt3 activates the canonical Wnt pathway in primitive ectoderm cells causing *β*-catenin to translocate to the nucleus where it binds to the promoter of the primitive streak marker *Brachyury (T)* ([@ref258]) and the proximal enhancer of *Nodal*, inducing transcription of *T* and *Nodal* on the posterior side of the embryo. As a result, Nodal, BMP4, and Wnt3 expression are maintained along the posterior axis of the embryo, allowing for the establishment, elongation, and maintenance of the streak ([Figure 2](#fig2){ref-type="fig"}). Concurrently, Wnt3 signaling causes posterior primitive ectoderm cells to undergo an EMT, by downregulating the expression of E-cadherin, allowing them to migrate, converge at, and ingress through, the streak.

Anterior primitive ectoderm cells do not undergo an EMT (due in part to Nodal and Wnt3 signaling inhibition in this part of the embryo; [Figure 2](#fig2){ref-type="fig"}) and therefore do not ingress through the streak. These cells form the third multipotent germ layer, the (definitive) ectoderm ([Figure 2](#fig2){ref-type="fig"}; Section "The Definitive Ectoderm").

Failure to gastrulate results in embryonic lethality shortly after implantation ([@ref52]; [@ref144]). For example, embryos lacking functional Nodal, Wnt, and/or BMP4 signaling show delayed and/or failure to initiate primitive streak formation and abnormal mesendoderm development ([@ref298]; [@ref52]; [@ref162]; [@ref207]; [@ref258]; [@ref164]; [@ref294]).

Following the completion of gastrulation at \~7.5 dpc ([@ref286]) and before the initiation of organogenesis (\~8.0 dpc), the mouse embryo inverts, bringing the definitive ectoderm to the outside, and the definitive endoderm to the inside of the embryo, while the definitive mesoderm remains as the middle layer.

The Definitive Ectoderm {#sec5}
-----------------------

Definitive ectoderm is bipotential, being able to differentiate into surface ectoderm or neurectoderm at 7.0 dpc ([@ref140]). Unlike the mesendoderm lineages, which have a variety of lineage markers that have been studied and confirmed both *in vitro* and *in vivo* (including *Mixl1, T, Flk1,* and *Sox17*) ([@ref7]; [@ref105]), there is a paucity of definitive ectoderm markers. Two potential markers, *Penk1* and *Pard6b*, have been suggested based on a neural differentiation protocol for mouse embryonic stem cells (mESCs) ([@ref92]). The expression of these potential *in vitro* markers has yet to be confirmed in the 6.5--7.0 dpc embryo. The lack of markers and the transient appearance of definitive ectoderm ([@ref92]; [@ref140]) means that much is still unknown about the molecular mechanisms driving its formation and contributing to its properties ([@ref144]; [@ref249]; [@ref7]; [@ref140]). However, once formed, definitive ectoderm responds differentially to BMP4 ([@ref92]; [@ref140]): Lineage commitment into surface ectoderm or neurectoderm relies, in part, on the presence or absence of BMP4-mediated SMAD1/5/8 signaling, respectively. BMPR1a^−/−^ embryos fail to produce surface ectoderm and instead upregulate genes, which result in neurectoderm differentiation ([@ref58]; [@ref59]).

The Role of the Anterior Visceral Endoderm in Establishing the Definitive Ectoderm {#sec6}
----------------------------------------------------------------------------------

As well as their roles in streak formation and mesendoderm production, Nodal, BMP4 and Wnt3 signaling are required for the anterior movement of the distal visceral endoderm (DVE) from 5.5 dpc from the distal tip of the embryo, and its differentiation to anterior visceral endoderm (AVE) by 6.0 ([Figure 2](#fig2){ref-type="fig"}; [@ref233]; [@ref19]; [@ref242]; [@ref102]). The AVE promotes definitive ectoderm formation by secreting Nodal antagonists including Cerberus-like 1 (Cer1) and Left-right determining factor 1 (Lefty1), and the Wnt antagonist Dickkopf1 (Dkk1) ([Figure 2](#fig2){ref-type="fig"}; [@ref210]; [@ref123]; [@ref240]; [@ref102]). Thus, the feedback system between Nodal, Wnt, and BMP4 present on the posterior side of the embryo is disrupted on the anterior side resulting in failure of the anteriorly located primitive ectoderm cells to undergo EMT and migrate through the posterior-placed streak. This population of pluripotent cells is then fated to become the definitive ectoderm, by 7.0 dpc ([Figure 2](#fig2){ref-type="fig"}). Consistent with this, \~6.5 dpc embryos cultured *ex vivo* in the presence of the Nodal inhibitor SB431542 ([@ref104]) fail to produce mesendoderm on the posterior side of the embryo. Rather, both the anterior and the posterior primitive ectoderm differentiate into definitive ectoderm derivatives including neurectoderm and surface ectoderm ([@ref140]). Similarly, Nodal^−/−^ epiblast explants fail to form mesoderm and instead prematurely differentiate into neurectoderm by \~6.5 dpc ([@ref149]; [@ref37]).

The Role of the Node in Patterning the Definitive Ectoderm {#sec7}
----------------------------------------------------------

At 7.0--7.5 dpc, a transient population of \~250 ciliated *HNF-3*β^+^ cells, known as the node, form at the distal tip of the embryo. These cells are responsible for distributing Nodal in a clockwise direction across the embryo to establish the embryonic left-right axis and exist until \~9.0 dpc ([@ref298]; [@ref52]; [@ref244]; [@ref50]; [@ref180]; [@ref289]; [@ref136]; [@ref11]).

Primitive ectoderm cells that migrate through the node toward the anterior (i.e., future head end) give rise to the mesodermal prechordal plate and notochord along the embryo's midline ([@ref244]). These structures are important signaling centers for the generation of the overlying neural plate and subsequent patterning of the neural tube (discussed below). Failure to form the node and/or notochord results in embryonic lethality ([@ref4]).

At \~7.0 dpc, the node secretes BMP4 antagonists, including Chordin, Noggin, and Follistatin, which dampen the gradient of BMP4 secreted from the proximal EXE ([Figure 2](#fig2){ref-type="fig"}; [@ref155]; [@ref12]; [@ref30]). The portion of the definitive ectoderm closest to the node, where BMP4 activity is low, differentiates into neurectoderm---the neural plate---which expresses *Sox1* followed closely (in the mouse) by the expression of *Pax6* ([@ref255]; [@ref245]). The neural plate can be recognized morphologically as a pseudostratified columnar sheet of neuroepithelium symmetrically placed along the anterior midline of the embryo. Its induction not only requires node-assisted mitigation of BMP4 activity but also signals from the underlying mesodermal tissue---the notochord and the prechordal plate ([@ref76]), as well as inhibition of ERK activity ([@ref812]).

In the proximal definitive ectoderm, where BMP4 activity is high, there is activation of the SMAD1/5/8 signaling pathway. SMAD complexes bind to epidermal DNA response elements resulting in the transcription of genes involved in surface ectoderm specification including members of the keratin family: early markers include *K8, K18,* and *K19*, followed by the more mature markers, *K14* and *K17* ([@ref263]; [@ref92]). By 7.5 dpc, the definitive ectoderm is fully committed to either surface ectoderm or neurectoderm and BMP4 exposure no longer has the ability to promote nor inhibit lineage commitment as cells have lost competence to form the opposing tissue ([@ref140]).

Thus, in the mouse, *Sox1* expression demarcates neural commitment ([@ref191]; [@ref10]). Its expression is restricted firstly to the developing neurectoderm, and following neurogenesis, to the mitotically active pool of neural stem cells ([@ref190]). *Sox2* and *Sox3* expression are also required for neural specification though their expression begins earlier in development ([@ref281]).

Neural Tube Formation and Dorsal-Ventral Patterning of the Spinal Cord {#sec8}
----------------------------------------------------------------------

From 7.5 dpc, rapid symmetric cell division causes a thickening of the *Sox1^+^* neural plate which then begins to fold, elevate, and converge at the midline ([Figure 4](#fig4){ref-type="fig"}; [@ref290]; [@ref76]; [@ref45]). Time-lapse imaging shows the hindbrain and spinal cord regions closing in a bi-directional zipper-like manner while the midbrain region undergoes "buttoning-up," and the process is completed with closure of the caudal (9 dpc) and rostral (10.5 dpc) neuropores ([@ref199]).

![Formation and patterning of the mouse neural tube. (A) The pseudostratified columnar epithelium of neural plate forms by 7.5 dpc. The lateral edges of the neural plate then **(B)** elevate and **(C)** fold by \~8.0 dpc before **(D)** converging at the midline and closing by \~8.5 dpc. Shh (red arrows) and BMP inhibitors secreted from the floor plate, and BMP4/7 (green arrows) secreted from the roof plate act to pattern the neural tube along its ventro-dorsal axis, giving rise to the layers of the spinal cord ([@ref76]). Key: V, ventral; D, dorsal; L, left; R, right.](fphys-10-00705-g004){#fig4}

During this time, morphogen activity gradients serve to pattern the tube dorsoventrally. By \~8.5 dpc, the ventral side of the neural tube (i.e., the side closest to the underlying notochord and prechordal plate) transitions to the floor plate ([Figure 4](#fig4){ref-type="fig"}) in response to Sonic hedgehog (Shh) secreted from the node, prechordal plate and notochord prior to neural tube formation. Fate mapping studies show that floor plate cells may also arise from a common precursor cell that gives rise to both the notochord and floor plate ([@ref108]). In response to Shh, the floor plate itself now acts as a primary signaling center producing Shh up until \~14.5 dpc ([Figure 4](#fig4){ref-type="fig"}; [@ref65]; [@ref60]), and establishing a gradient that helps pattern the ventral side of the neural tube ([Figure 4](#fig4){ref-type="fig"}; [@ref142]; [@ref76]; [@ref206]).

A small population of cells in contact with the overlying surface ectoderm forms the roof plate, in part due to BMP4/7 signaling from this overlying structure. The roof plate itself becomes a dorsal organizer secreting BMPs and other morphogens, which establish dorsal-ventral gradients ([@ref76]). The floor plate, notochord and prechordal plate modify these gradients by secreting BMP antagonists including chordin and noggin ([@ref155]; [@ref195]).

In the presumptive spinal cord, these morphogen activity gradients help establish a sequence of neural cell types running ventral to lateral as follows: V3 neurons, motor neurons, V2 then V1 then V0 interneurons, and D2 then D1 interneurons. Mice that lack functional Shh signaling show disruptions to node and notochord function, followed by the inability to form floor plate ([@ref60]), resulting in abnormal CNS patterning ([@ref48]). Shh mutant mice also have craniofacial, visual, and axial defects ([@ref48]; [@ref103]). Similarly, CNS patterning is disrupted in mice lacking functional roof plate cells. Selective genetic ablation of roof plate cells in \~9.5 dpc mouse embryos disrupts the activity gradients of BMPs, resulting in failure to form dorsal interneurons ([@ref109]; [@ref280]).

Neurogenesis {#sec9}
------------

Following the rapid proliferation of the *Sox1^+^* neuroepithelium ([@ref238]; [@ref101]), some of these cells begin to differentiate into radial glia (RG) cells in response to autocrine Notch, Wnt, and Fgf signaling ([@ref91]; [@ref6]; [@ref151]; [@ref114]; [@ref215]; [@ref56]) and paracrine signaling from the cortical hem of the telencephalon (the future cerebral cortex) ([@ref39]). These RG cells upregulate the expression of markers including brain lipid binding protein (BLBP), glutamate-aspartate transporter (GLAST), glial fibrillary acidic protein (GFAP), and vimentin.

RG cells are the primary progenitor cells of the developing and post-natal CNS. They firstly give rise to neurons from \~10.0--14.5 dpc, followed by the production of astrocytes and oligodendrocytes (glia) by \~15.0 dpc ([Figure 5](#fig5){ref-type="fig"}; [@ref125]; [@ref6]).

![Cortical neurogenesis in the mouse. Following neural plate formation at 7.5 dpc, neuroepithelial cells (NEC) differentiate into mitotically active neural progenitor cells known as radial glia (RG) by \~9.0 dpc. RG undergo either symmetrical division to produce two RG daughter cells, or asymmetric division to produce one RG daughter cell and a terminally-differentiated neuron (N), or an intermediate progenitor cell (IPC), or a mature glial cell (G). IPCs are capable of undergoing symmetrical division to form neurons. N and IPCs migrate along the axons of the RG cells from the ventricular zone (VZ), through the subventricular zone (SVZ) and into the upper cortical layers of the developing brain.](fphys-10-00705-g005){#fig5}

Cortical RG cells can assume a variety of fates ([Figure 5](#fig5){ref-type="fig"}): in the presence of Fgf2 \[secreted from cortical progenitors throughout the ventricular zone (VZ) ([@ref215])\], they self-renew to enlarge the progenitor pool, while in the absence of Fgf2 signaling they produce the intermediate progenitor cell (IPC; also known as a basal progenitor cell; [@ref201]). The importance of Ffg2 signaling is highlighted in FGFR1/2 knockout embryos, which display decreased neural progenitor and mature neuronal cell number, and as a result, decreased cortical size ([@ref265]; [@ref236]).

As neurogenesis progresses, RG cells increasingly give rise to daughter cells that exit the cell cycle and undergo terminal differentiation, resulting in the progenitor pool gradually decreasing over time, and eventual near-cessation of neurogenesis (at least in mammals). From 15.0 to 19.0 dpc, gliogenesis begins as RG cells switch from producing neurons to producing glia: newly born *NeuN*^+^ neurons secrete factors, including CT-1 and IL-6 family cytokine leukemia inhibitory factor (LIF), that instruct the production of GFAP^+^ astrocytes from RG cells ([@ref15]) and O4^+^ oligodendrocytes ([@ref200]). Following embryonic neurogenesis, the mammalian adult brain has limited capacity to produce neurons. Two regions, the subventricular zone (SVZ) and the dentate gyrus of the hippocampus, retain this ability ([@ref159]; [@ref161]; [@ref69]; [@ref264]).

Embryonic Stem Cells: An *in Vitro* Model of Embryogenesis {#sec10}
==========================================================

Properties of Embryonic Stem Cells {#sec11}
----------------------------------

mESC lines are generally derived from blastocysts (3.5--4.5 dpc) ([@ref67]) and are defined by: (1) the ability to self-renew while maintaining a normal karyotype and (2) pluripotency---the ability to differentiate into each of the \~200 somatic cell types of the developing embryo and adult, including germ-line cells ([@ref67]). These properties allow ESCs to be used as an *in vitro* model of embryogenesis. In particular, they provide the opportunity for employing more facile approaches to understanding the molecular mechanisms driving development compared to studying embryos themselves.

ESCs can be used to recapitulate aspects of embryonic morphology. For example, when cultured in suspension, embryoid bodies (EBs) form, which self-assemble into an outer extraembryonic endoderm layer separated from a core of pluripotent cells by an ECM; i.e., mimicking the relationship of the 5.5 dpc embryo ([@ref53]; [@ref28]). Similarly, hESCs grown on micropattern plates (to control colony size and density) undergo differentiation and embryologically relevant self-organization into cells of the three germ layers: an inner Sox2^+^ neurectoderm core, underlying a T^+^ mesoderm layer and Sox17^+^ endoderm layer surrounded by a Cdx2^+^ TE-like outer layer ([@ref273]).

ESCs can also be driven sequentially through populations of cells, which recapitulate the ontogeny of embryonic lineage commitment *in vivo* ([@ref204]; [@ref137]; [@ref92]; [@ref222]; [@ref257]; [@ref170]). The close resemblance between ESC differentiation and lineage commitment in embryos in terms of cell signaling, gene and protein expression, and metabolic and epigenetic profiles provides further evidence that ESCs act as a good model system for understanding the molecular mechanisms underlying embryonic development ([@ref203]; [@ref292]; [@ref147]; [@ref92]; [@ref173]; [@ref202]; [@ref232]).

Pluripotency and Self-Renewal in ESCs {#sec12}
-------------------------------------

Establishing the pluripotency of the line is crucial: The gold standard is tetraploid complementation ([@ref250]; [@ref64]; [@ref172]) whereby diploid mESCs aggregated with tetraploid mouse embryos produce chimeras in which the embryo *proper* is almost completely (if not completely) derived from the mESCs, and with the chimeras capable of germline transmission. The more commonly employed approach, however, is to generate mouse chimeras where the mESCs are injected into the ICM of diploid blastocysts and shown to contribute to all tissues of the animal including, preferably, the germline ([@ref98]). Less stringent tests of pluripotency are still informative. These include injecting cells under the kidney capsule of mice to produce teratomas containing cells derived from all three germ layers, and differentiation of the cells in tissue culture to produce cells from all three layers. For the latter, spontaneous differentiation to all three germ layers for mESCs should occur with the removal of LIF.

The developmental potential of pluripotent cells depends on how they are derived and/or cultured ([@ref227]). This pluripotency continuum is now known to be composed of at least four different metastable states: naïve, ground, intermediate/formative, and primed. Each state has different transcriptional, epigenetic, and metabolic regulation underlying a cell's ability to differentiate ([@ref152]; [@ref113]; [@ref227]; [@ref243]).

1.  *Naïve:* mESCs grown in the presence of LIF (recombinant or secreted from a feeder layer of MEFs) and BMP4 (recombinant or present in serum) ([@ref176]; [@ref291]; [@ref100]) are classified as naïve ([@ref227]). This naïve pluripotent population contains cells with high (transcriptionally stable) and low (prone to differentiate) expression levels of *Stella* and *Nanog* ([@ref95]).

2.  *Ground state:* naïve mESCs cultured in 2i conditions (in which GSK and MEK1 pathways are chemically inhibited) are driven back to ground-state pluripotency consisting of a homogenous population of pluripotent *Stella*^+^ cells. Ground-state cells contain hypomethylated DNA, allowing robust expression of pluripotency genes ([@ref227]).

3.  *Primed:* pluripotent cells that have lost the expression of naïve pluripotency markers such as *Nanog*, and instead upregulate the expression of primitive ectoderm markers such as *Fgf5*. This includes, in particular, EpiSC lines, which are derived from post-implantation epiblast (generally, 5.5--6.5 dpc) ([@ref127]; [@ref283]; [@ref174]; [@ref227]). EpiSCs resemble hESCs in the sense that both rely on the exogenous Activin A (to mediate Smad signaling) and Fgf2-mediated Erk1/2 signaling for self-renewal. Unlike naïve, ground-state and formative/intermediate pluripotent cells, primed pluripotent cells cannot integrate into the morula or blastocyst but can be grafted into the post-implantation epiblast and contribute to the three germ layers, but not germ cells ([@ref165]).

4.  *Intermediate/formative*: pluripotent cells that have characteristics of both naïve and ground-state pluripotency ([@ref227]). These cells display significant remodeling of the epigenetic landscape, reconfiguration of gene regulatory networks, and preferentially utilize glycolytic metabolism compared to naïve cells and can form cells from the three germ layers as well as germline cells.

Regulation of Pluripotency and Self-Renewal {#sec13}
-------------------------------------------

Unlike mammalian somatic cells, mESCs have a very short cell cycle (\~12 h) ([@ref182]; [@ref209]), due in part to their (1) G1-phase lasting for only 1.5 h ([@ref33]) and (2) lack of regulatory mechanisms that normally govern the G1-to-S-phase transition ([@ref209]). The consequence is that mESCs undergo rapid cell division while maintaining pluripotency and self-renewal.

The molecular circuitry at the heart of pluripotency and self-renewal is a core network of transcription factors comprised of Oct4, Nanog, and Sox2 ([Figure 6](#fig6){ref-type="fig"}). The activity of this core network is delicately balanced and depends on the concentrations, interactions between, and various functions of these three proteins ([@ref177]; [@ref145]; [@ref254]; [@ref287]). These transcription factors collectively regulate the expression of 353 genes, including themselves, as well as genes of the "extended pluripotency network," such as *Fgf4, Rex1, Klf2*, and *Klf4* ([Figure 6](#fig6){ref-type="fig"}; [@ref27]; [@ref181]; [@ref287]). The purpose of the extended network is at least 2-fold: (1) Its circuitry feeds forward to sustain core network activity and (2) it suppresses lineage commitment pathways ([Figure 6](#fig6){ref-type="fig"}; [@ref27]; [@ref106]; [@ref85]; [@ref41]; [@ref287]; [@ref166]) through, for example, promotion of the addition of repressive epigenetic marks to lineage-commitment genes. Many differentiation-associated genes contain bivalent histone modifications such that they have both active (H3K4me3) and repressive (H3K27me3) epigenetic marks ([@ref20]). Genes exhibiting this profile (the majority of which are transcription factors, morphogens and cell-surface molecules involved in developmental progression) are thought to be "primed" for transcription when the conditions are favorable ([@ref20]; [@ref268]).

![Regulation of the core and extended pluripotency networks in mouse embryonic stem cells. Maintenance of pluripotency and self-renewal is governed by external stimuli (red), which act on various signalling pathways (green) that regulate the expression of the extended (blue) and core (purple) pluripotency networks. In turn, the expression of transcription factors of the core circuitry regulates their own expression, as well as the expression of other factors involved in differentiation and/or self-renewal (orange). Figure adapted from data published in: ([@ref110]; [@ref163]; [@ref291]; [@ref183]; [@ref87]; [@ref21]; [@ref127]; [@ref237], [@ref239]; [@ref47]; [@ref156]; [@ref178]; [@ref85]; [@ref100]; [@ref282]; [@ref119]; [@ref152]; [@ref174]; [@ref212]; [@ref61]; [@ref135]; [@ref88]; [@ref197]; [@ref259]).](fphys-10-00705-g006){#fig6}

The net output of these interconnected circuits keeps ESCs poised: The activity of the core network is such that self-renewal and pluripotency are maintained but the system can rapidly tip over into differentiation ([Figure 7](#fig7){ref-type="fig"}). This can be achieved, for example, by perturbing the expression of one or more pluripotency network factors or by exposing cells to appropriate lineage commitment signals ([@ref254]). Pluripotency factors themselves can also act as lineage specifiers ([@ref145]): A 2-fold increase in *Oct4* expression promotes mesendoderm differentiation ([@ref177]), while overexpression of *Sox2* favors neurectoderm and represses mesendoderm differentiation ([@ref254]).

![Cell signalling events that mediate the switch between self-renewal and differentiation in mouse embryonic stem cells. **(A)** LIF binds to the LIF receptor (LIFR) resulting in heterodimerisation with glycoprotein-130 (gp130). Downstream JAK proteins become phosphorylated, and in this active state phosphorylate tyrosine residues on the receptor complex. STAT3 can then dock to the receptor, is then phosphorylated at Y705, and homodimerises before translocating to the nucleus where it induces the transcription of self-renewal genes. LIF also activates the PI3K pathway, in which PIP~2~ is converted to PIP~3~ resulting in the downstream phosphorylation of AKT at S473 and T308. This enhances self-renewal by upregulating the expression of Nanog, and by promoting cell cycle progression. **(B)** BMP4 binds to its cognate BMP receptor (BMPR) resulting in the phosphorylation of SMAD1/5/8. Once phosphorylated, SMAD1/5/8 forms heterodimers with SMAD4, which translocate to the nucleus resulting in transcription of inhibitor-of-differentiation (*Id*) genes. SMAD signaling also results in the upregulation of the phosphatase DUSP9 which acts as a negative regulator of ERK, thereby inhibiting differentiation. **(C)** LIF also activates the MAPK/ERK pathway to promote differentiation in the face of maintaining self-renewal. The balance can be tipped toward differentiation by the presence of Fibroblast Growth Factor (FGF4), which upregulates the activity of the MAPK/ERK pathways, as does **(D)** L-proline. L-proline enters the cell *via* the Sodium-coupled Neutral Amino Acid Transporter (SNAT)-2 where it activates mTOR to induce the differentiation of mESCs to early primitive ectoderm-like (EPL) cells. Figure adapted from data published in: ([@ref292]; [@ref183]; [@ref21]; [@ref274]; [@ref100]; [@ref212]; [@ref88]).](fphys-10-00705-g007){#fig7}

LIF-Mediated Signaling and the Control of mESC Self-Renewal {#sec14}
-----------------------------------------------------------

LIF exerts its effects on mESCs by binding to a receptor complex consisting of the LIF receptor (LIFR*β*) and the glycoprotein-130 (gp130). The signal is transduced *via* three main pathways: (1) JAK/STAT signaling, (2) PI3K/AKT signaling, and (3) MAPK/ERK signaling ([Figure 7](#fig7){ref-type="fig"}) \[for a detailed review, see ([@ref100])\]. The first two pathways promote self-renewal, while the third promotes differentiation. Under self-renewing conditions, the balance lies in favor of self-renewal but with the cells poised to differentiate.

### JAK/STAT3 Signaling {#sec15}

LIF binding to the LIFR-gp130 complex results in phosphorylation and homodimerization of the transcription factor STAT3 ([Figure 7](#fig7){ref-type="fig"}). Activation of this pathway leads to the upregulation of target transcription factors including Kruppel-like zinc finger (Klf4), which preferentially activates the expression of *Sox2*. Sox2 protein forms a heterodimer with Oct4 ([@ref85]; [@ref178]), which binds Oct-Sox elements in promoter regions of target genes including *Oct4* and *Sox2* themselves, as well as *Nanog* ([@ref47]; [@ref61]; [@ref197]), resulting in a self-reinforcing mechanism for maintaining the activity of the core pluripotency network and hence self-renewal ([Figure 6](#fig6){ref-type="fig"}).

### PI3K/AKT Signaling {#sec16}

Stimulation of the LIF receptor complex concurrently activates the class I~A~ family of lipid kinases known as phosphatidylinositol-3 phosphate kinases (PI3K) ([Figure 7](#fig7){ref-type="fig"}). Through the downstream phosphorylation of AKT at threonine-308/serine-473 (T308/S473), cell cycle progression/proliferation is stimulated and, as with the STAT3 pathway, self-renewal is maintained ([@ref110]; [@ref183]). In the presence of the PI3K inhibitors, LY294002 or Deltap85, a reduced ability to self-renew is observed with the increased propensity of cells to undergo changes in morphology. Phosphorylated STAT3 levels are not altered, thus suggesting an independent mechanism by which PI3K maintains self-renewal ([@ref183]). The PI3K/AKT pathway activates the transcription of *T-box (Tbx)-3*, which is primarily responsible for upregulating the expression of *Nanog* ([Figure 6](#fig6){ref-type="fig"}; [@ref237], [@ref239]; [@ref178]). *Nanog^−/−^* mESCs are still capable of self-renewal (probably due to the compensatory mechanisms involving Oct4 and Sox2), but they have a greater propensity to differentiate into *Gata6^+^* extraembryonic endoderm ([@ref163]).

### MAPK/ERK Signaling {#sec17}

LIF-mediated MAPK/ERK pathway activation represses the expression of *Tbx3, Klf4*, and *Nanog* ([@ref87]; [@ref178]; [@ref119]), thereby poising ESCs for differentiation when conditions are favorable ([Figure 7](#fig7){ref-type="fig"}; [@ref21]; [@ref88]).

With a combination of LIF, the MEK inhibitor (PD0325091) and glycogen synthase kinase (GSK)-3*β* inhibitor (CHIR99021) (also known as the 2i + LIF system), mESCs are maintained in a ground state ([@ref282]; [@ref152]; [@ref259]): MAPK/ERK pathway activity is no longer present to poise the system for differentiation and CHIR99021 makes the cells more resistant to other pro-differentiation signals such as *Fgf4* ([@ref127]; [@ref174]; [@ref135]).

BMP4-Mediated Signaling in mESCs Suppresses Lineage Commitment {#sec18}
--------------------------------------------------------------

BMP4 regulates the expression of genes within the core and extended pluripotency networks as well as inhibiting genes involved in lineage commitment ([Figure 6](#fig6){ref-type="fig"}; [@ref291]; [@ref47]; [@ref156]). BMP4-mediated SMAD1/5/8 signaling inhibits differentiation by inducing transcription of inhibitor of differentiation (*Id*) genes (specifically *Id1*), which act to repress lineage commitment during early embryogenesis ([Figure 7](#fig7){ref-type="fig"}; [@ref291]). Overexpression of *Id1* in mESCs maintains self-renewal even in the absence of LIF and serum through upregulation of *Nanog* expression ([@ref291]; [@ref212]). In contrast, *Id1^−/−^* mESCs fail to self-renew and preferentially differentiate into *T^+^* mesendoderm-derived cells ([@ref212]).

BMP4 also supports self-renewal by attenuating the activity of differentiation-inducing MAPK/ERK pathway *via* upregulation of the expression of the phosphatase DUSP9 ([Figure 7](#fig7){ref-type="fig"}; [@ref138]). DUSP9 dephosphorylates ERK in mESCs (but not somatic cells) ([@ref138]) and its overexpression in mESCs results in further reduction of phosphorylated ERK. In contrast, siRNA knockdown of DUSP increases ERK activity even in the presence of BMP4 resulting in decreased expression of *Nanog* and *Rex1* mRNA as well as decreased alkaline phosphatase staining ([@ref138]), all of which are hallmarks for movement away from pluripotency.

Thus, provided the external environment continues to supply sufficient concentrations of LIF and BMP4 to mESCs both the core and extended pluripotency networks will have sufficient activity, and lineage commitment pathways will be sufficiently repressed, to maintain pluripotency and self-renewal over extended periods of time. Once loss of pluripotency is instigated, however, BMP4 plays roles which then promote various stages of embryological development. For example, once loss of pluripotency in mESCs occurs, BMP4 acts to direct lineage commitment; e.g., the production of mesendoderm and epidermal populations is favored over neurectoderm ([@ref291]; [@ref92]; [@ref297]; [@ref212]). Similarly, BMP4 is known to be a potent inducer of differentiation that is required for patterning definitive ectoderm in the embryo along the proximal/distal axis (Section "The Role of the Node in Patterning the Definitive Ectoderm").

Neurectoderm Induction and Subsequent Differentiation {#sec19}
-----------------------------------------------------

In the \~7.5 dpc embryo, the progenitor population that gives rise to the neurectoderm (and surface ectoderm) lineage is the definitive ectoderm, located on the anterior portion of the embryo where Nodal signaling is low/absent ([Figure 2](#fig2){ref-type="fig"}; Sections "Gastrulation and the Formation of the Three Germ Layers," "The Definitive Ectoderm," "The Role of the Anterior Visceral Endoderm in Establishing the Definitive Ectoderm"). This is a poorly understood lineage due in part to its transient nature *in vivo* and lack of both *in vivo* and *in vitro* molecular signatures. To date, very few studies have attempted to understand neural lineage commitment at this stage of development. Recently, a population of ectodermal precursors has been established *in vitro* ([@ref143]). These cells, derived from EpiSCs cultured in the presence of the Nodal inhibitor SB431542, have a gene expression profile similar to that of the 7.0--7.5 dpc anterior embryo and active chromatin marks in the promoter regions of both neurectoderm and surface ectoderm genes ([@ref143]). These cells therefore represent an *in vitro* equivalent population of the definitive ectoderm lineage, primed to differentiate to neurectoderm when conditions are favorable.

As with the embryo, *Sox1* is the earliest neurectoderm marker expressed in differentiated mESCs ([@ref191]; [@ref10]). When mESCs are cultured in conditions that permit neurectoderm differentiation (low plating density, serum-free medium supplemented with N2B27), they firstly undergo rapid downregulation of *Oct4*, followed by the upregulation of *Fgf5* ([@ref292]; [@ref147]). Under these same conditions, about 60% mESCs express *Sox1* (as measured by a GFP reporter line) by day 4 of monolayer culture, followed by the early neural progenitor marker Nestin by days 5--6 ([@ref147]). Furthermore, forced expression of *Sox1* in mESCs triggers differentiation to neurectoderm ([@ref245]), while siRNA knock-down of *Sox1* in neurectoderm cells induces them to differentiate to *Pax6*^+^ RG cells ([@ref245]). RG cells are considered the primary progenitor cell population of the embryonic nervous system, which can give rise to both neurons and glia *via* IPCs (Section Neurogenesis; [Figure 5](#fig5){ref-type="fig"}; [@ref196]; [@ref25]). Overexpression of *Pax6* in mESCs induces the differentiation to BLBP^+^/Vimentin^+^ RG cells that later give rise to *β*III-tub^+^/NeuN^+^ post-mitotic neurons ([@ref245]). *Pax6* is thus a key regulator involved in mediating the switch between mouse neuroepithelial self-renewal and radial glial differentiation ([@ref217]).

Rather than being instructive signals, many molecules shown to permit neurectoderm formation in the mouse (such as chordin, noggin, and follistatin) are antagonists of BMP4 signaling, which prevent downstream SMAD signaling (Section "The Role of the Node in Patterning the Definitive Ectoderm"). Results from the following studies indicate that neurectoderm production from ESCs arises by a default mechanism of differentiation ([@ref97]; [@ref261]; [@ref167]): (1) SMAD4^−/−^ mESCs cultured in serum-free conditions give rise to Nestin^+^ neural progenitors and then βIII-tub^+^ neurons within 24 h ([@ref261]). (2) mESCs cultured with the BMP antagonist noggin or chordin (or transfected with a noggin or chordin expression plasmid) differentiate into neural cells within 24 h ([@ref81]). (3) hESCs cultured at low density with noggin differentiate into neural progenitor cells ([@ref62]). (4) mESCs cultured at low density in chemically defined medium for 4 h differentiate to Sox1^+^ neurectoderm, followed by the differentiation to Nestin^+^ neural progenitors and then βIII-tub^+^ neurons after an additional 20 h, at the expense of mesoderm and endoderm cell types ([@ref228]). This occurs even when mESCs are cultured in phosphate-buffered saline ([@ref228]).

However, other studies have shown that instructive factors stimulate neurectoderm production. For example, retinoic acid (RA) (which is also instructive *in vivo*) is used frequently for *in vitro* differentiation of mESCs and hESCs to the neural lineage ([@ref66]; [@ref234]; [@ref256]). In mESCs, RA mediates its effects through ERK signaling, firstly by repressing *Oct4* expression ([@ref82]), followed by regulating Fgf signaling.

Fgf4 is the primary inducer of ERK signaling in mESCs. This pathway poises mESCs for differentiation and when conditions are favorable ([Figure 7](#fig7){ref-type="fig"}; Section "LIF-Mediated Signaling and the Control of mESC Self-Renewal") permits them to progress to an early primitive ectoderm-like (EPL) population ([@ref235]), a differentiation process analogous to the *in vivo* ICM to primitive ectoderm transition (see Section "The Stage-Specific Effect of Amino Acids on ESCs"). Following a short burst of *Fgf4*-mediated ERK activity, RA gradually downregulates the expression of *Fgf4* and p-ERK, which is accompanied by an increase in *Sox1^+^* neurectoderm cells ([@ref234]; [@ref208]). Similarly, mouse EpiSCs cultured in the presence of the ERK inhibitor PD032590 for 24 h show decreased expression of *Oct4*, increased expression of *Sox1* mRNA and a significant increase in the percentage of *Sox1*-GFP^+^ cells compared to untreated cells ([@ref812]). In addition to this, even in the presence of mesendoderm-inducing factors (including CHIR99021 and Activin A), inhibition of ERK activity by PD032590 (1) decreases the expression of the mesendoderm markers *Mixl1, T, FoxA2* and *Sox17,* and (2) inhibits the translocation of *β*-catenin to the nucleus preventing an EMT from occurring---a feature characteristic of definitive ectoderm-derived cells (Section "Gastrulation and the Formation of the Three Germ Layers") ([@ref812]).

Similarly, in hESCs, Fgf-mediated ERK1/2 signaling activates Poly-(ADP-ribose)-Polymerase-1 (PARP-1), which binds directly to the *Pax6* promoter (the first neurectoderm marker expressed in the human, followed closely by expression of *Sox1*) ([@ref185]; [@ref296]), resulting in neurectoderm induction ([@ref293]). Pharmacological inhibition of Fgf receptor, ERK1/2 or PARP-1 prior to the onset of neurectoderm induction decreases the percentage of *Pax6^+^* and *Sox2^+^* cells. Taken together, complex, time-dependent modulation of ERK activity is required for ontogenetic progression to neurectoderm.

The Notch signaling pathway has also been implicated in neurectoderm induction and regulation of neurectoderm proliferation and neuronal differentiation ([@ref147]; [@ref231]; [@ref22]; [@ref211]). In the embryo, Notch works in conjunction with Fgf signaling from \~7.5 dpc to maintain the neuroepithelial pool, while blocking neurogenesis ([@ref147]; [@ref231]). Notch is cleaved by γ-secretase after binding its reciprocal membrane receptor on a neighboring cell ([@ref124]). Now in its activated form, the Notch Intracellular domain (NotchIC) translocates to the nucleus where it controls the transcriptional regulation of downstream target genes, including the repressor genes *Hes1* and *Hes5* ([@ref179]). Inhibition of Notch signaling by the *γ*-secretase inhibitor L-685-458 in 46C mESCs ([@ref292]) results in few *Sox1*-GFP^+^ neurectoderm cells, most of which remain as Oct4^+^ mESCs. Similarly, genetic ablation of NotchIC binding partner, RBPJ, results in less than 10% of cells expressing the pan-neural marker *Sox2* as well as *Pax6* and BLBP ([@ref147]). In the presence of the *γ*-secretase inhibitor DAPT, a significant increase in the expression of p63, a marker of early surface ectoderm commitment, occurs in hESCs ([@ref246]). This suggests Notch is not only important for neural induction but also acts to control the fate of the definitive ectoderm lineage by inhibiting surface ectoderm production.

Notch maintains the neuroepithelial cell pool *via* activation of Hes1. Oscillations in *Hes1* expression occur in both mESCs and mouse neural stem cells and are believed to regulate the balance between proliferation and differentiation ([@ref223]): Sustained expression of *Hes1* in mESCs inhibits neurectoderm induction (and preferentially induces mesoderm differentiation), presumably as a result of the negative feedback on Notch signaling ([@ref120]). In wild-type neural stem cells, upregulation of *Hes1* expression prevents premature neuronal differentiation by repressing the expression of proneural genes including *Neurogenin2* and *Mash1* ([@ref192]).

During the mammalian cell cycle, the time taken to move through interphase (G1, S, and G2) and, in particular, how long cells spend in G1 largely determines their fate ([@ref36]; [@ref131]). Notch increases expression of CyclinD1, Cdk6 and phospho-retinoblastoma protein (p-Rb) in both mESC-derived and hESC-derived neuroepithelial cells allowing them to readily progress through the G1/S phases ([Figure 8](#fig8){ref-type="fig"}), thereby increasing proliferation rate ([@ref24]; [@ref55]; [@ref90]). Overexpression of CyclinD1/Cdk4 significantly shortens the G1 phase in neural stem cells, allowing cell-cycle progression and progenitor expansion to occur, while inhibiting neurogenesis ([@ref132]).

![Notch signaling in neural stem cells promotes cell-cycle progression and inhibits neurogenesis. During the mammalian cell cycle, the length of time it takes cells to move through interphase (G1, S and G2) and, in particular, how long they spend in G1, helps determine their fate. Transition between stages of the cell cycle is driven by a series of cyclin-dependent kinases (Cdks) binding to specific cyclins to promote cell-cycle progression. Notch signaling increases the expression of both CyclinD and Cdk4/6, indirectly allowing cells to progress past the restriction checkpoint (R) and into S phase, promoting proliferation. Notch also inhibits the cell-cycle inhibitors p21 and p27, which further promotes proliferation and prevents the expression of genes involved in neurogenesis such as *Nestin* and *Neurogenin1/2*.](fphys-10-00705-g008){#fig8}

Increases in PI3K and MAPK signaling accompany increases in Cdk6 and CyclinD1 mRNA expression and inhibition of PI3K and MAPK by Wortmannin and UO126, respectively, reduces Notch-mediated effects on proliferation ([@ref55]). In addition, Notch-mediated increases in Hes1 activity repress genes involved in negatively regulating the G1 phase of the cell cycle, including *p21* ([@ref112]) and *p27* ([@ref169]).

Cell-cycle regulation within the developing CNS acts to regulate the balance of stem cells, progenitors, neurons and glia. Just prior to undergoing differentiation to neuronal fates, neural progenitor cells have increased cell-cycle length due to a longer G1 phase ([@ref35]). Taken together, these data suggest that the length of time in which a neuroepithelial cell remains in G1 phase is a determinant of differentiation ([@ref35]).

The Role of Amino Acids During Development {#sec20}
==========================================

Nutrient Supply During Early Embryogenesis {#sec21}
------------------------------------------

Along with pyruvate and lactate, early embryos use amino acids as a source of nitrogen, in addition to their primary role as building blocks in protein production. Amino acids are now also appreciated to act as pH regulators, osmolytes and signaling molecules within various cell types, including those of the early embryo ([@ref72]; [@ref116]). In the mouse and human, the preimplantation embryo is exposed to all 20 common amino acids present in the maternal tubal fluid ([@ref43]; [@ref116]): Most non-essential amino acids (NEAA) are present at submillimolar concentrations (≤600 μM) while essential amino acids (EAA) tend to be present at lower concentrations (≤200 μM) ([@ref160]; [@ref130]; [@ref1]).

While preimplantation mouse embryos can develop to blastocysts in very simple culture media ([@ref154]; [@ref278]), including those without amino acids, this development is associated with a reduction in cleavage rates, blastocyst cell number, and embryo viability compared to their *in vivo* counterparts. Addition of all 20 amino acids to the culture medium significantly improves the number of zygotes that reach the blastocyst stage by 96 h of culture compared to embryos cultured without amino acids ([@ref128]). Hatching rates are also improved ([@ref73]; [@ref128]). However, addition of just NEAA + glutamine is more efficacious: Hatching rates are further improved and development to the blastocyst stage occurs by 72 h, equivalent to the time taken for this to occur *in vivo* ([@ref73]; [@ref128],[@ref129]; [@ref72]). NEAA + glutamine enhances development in two important ways: firstly, embryos from outbred strains are liberated from the 2-cell block ([@ref78]; [@ref74]). This *in vitro* arrest in development, which also occurs in other mammalian species including the 4--8 cell human embryo ([@ref23]), marks the time when the embryonic genome becomes activated ([@ref78]; [@ref29]; [@ref133]). Secondly, cleavage rates for the first three cell divisions are increased ([@ref71]; [@ref80]; [@ref129]). In contrast, addition of EAA to the culture medium prior to the 8-cell stage impairs viability and development to the blastocyst stage, but if added from the 8-cell stage stimulates blastocyst development, trophectoderm cell number, and hatching ([@ref128]).

In keeping with this poorly understood complexity, embryos dynamically express a range of amino-acid transporters in the pre-implantation stages suggesting they temporally exploit the use of amino acids to promote normal development ([@ref267]). However, the mechanisms by which individual amino acids drive the various stages of pre-implantation development are largely unknown and the many efforts to improve media for cultured embryos (to be used, say, in IVF) have been mostly empirical. The use of 2-stage media, where the amino acid content is switched largely from NEAA to EAA, is one of many examples ([@ref75]).

Maternal and umbilical blood also contain amino acids ([@ref160]; [@ref1]; [@ref116]) suggesting that these molecules play important roles in post-implantation development. For example, L-proline is present in circulating maternal plasma and umbilical venous plasma at a concentration of \~150 μM ([@ref43]). This *in vivo* concentration of L-proline is consistent with that required to stimulate the *in vitro* differentiation of mESCs to a second pluripotent population of EPL cells ([@ref204]; [@ref274]; [@ref252]). The embryo itself may be a source of L-proline *via* storage within its cells ([@ref13]) and/or within the blastocoel cavity ([@ref219]; [@ref72]). Other possible *in vivo* sources of L-proline include turnover of the collagen-rich ECM that separates the VE from the ICM, as well as ECM turnover that occurs during the process of implantation ([@ref77]).

The Stage-Specific Effect of Amino Acids on ESCs {#sec22}
------------------------------------------------

It is now clear that specific amino acids can strongly influence the emergent properties of ESCs, including self-renewal versus differentiation, rate of proliferation, apoptosis, cell shape change, EMT and its reverse, mesenchymal-to-epithelial transition ([@ref274]; [@ref40]; [@ref51]; [@ref220]; [@ref46]; [@ref224]; [@ref118]).

L-glutamine ([@ref38]) and L-threonine ([@ref213]; [@ref46]) in mESCs \[or L-methionine instead of L-threonine in hESCs ([@ref46]; [@ref224])\] maintain self-renewal and growth/survival. In contrast, L-proline induces differentiation to EPL cells, increases the rate of proliferation, and induces a change to flattened monolayer colonies in which cells undergo an EMT ([@ref40]; [@ref51]; [@ref54]).

Each of these amino acids control the emergent properties of ESCs using a broad spectrum of molecular machinery including signaling pathways, translational control, transcription factor regulatory networks, and modulation of the epigenetic landscape ([Figure 6](#fig6){ref-type="fig"}; [@ref40]; [@ref213]; [@ref51]; [@ref226]; [@ref46]; [@ref224]; [@ref54]; [@ref214]). A significant contributor to the last of these is the flux through, and the products produced by, the metabolic pathways specific to each amino acid, which lead to amino-acid-specific modulation of the epigenetic programs at both the DNA and histone levels (see below) ([@ref51]; [@ref224]; [@ref38]). These amino acids also stimulate common signaling pathways including ERK, PI3K/Akt and mTORC1 ([@ref274]; [@ref213]; [@ref224]; [@ref38]; [@ref54]; [@ref214]), and this signaling takes place in conjunction with the common signaling milieu mediated by the presence of LIF and BMP4 (see above) ([Figure 7](#fig7){ref-type="fig"}). Yet the cellular response of mESCs to L-proline is very different to that for L-glutamine and L-threonine. This indicates that the emergent properties of the ESC system can be very different even when the molecular mechanisms at play are largely similar. This is consistent with ESCs acting as a complex self-renewing and pluripotent system poised for differentiation, and in which subtle changes to the activity of common molecular mechanisms, in addition to amino-acid-specific mechanisms, can result in very different cell fates.

Two of these amino acids, L-threonine and L-methionine, are essential amino acids (EAAs) and therefore maternal sources of them are a requirement for normal mammalian development. The other two, L-glutamine and L-proline, are conditionally essential; i.e., they can be produced within embryonic cells but not necessarily manufactured at a sufficient rate to drive all aspects of normal development ([@ref284]; [@ref285]). Thus, for these conditionally essential amino acids, maternal supplementation is required for the embryo to pass some key developmental milestones. Threshold or higher concentrations of L-glutamine and/or L-proline in the maternal environment (e.g., in the tubal fluid) may be indicators of normal nutritional balance and act as 'go signals' for pregnancy/embryo development to continue.

### L-Glutamine Acts as a Survival and Self-Renewal Factor for ESCs {#sec23}

In mammalian cells, L-glutamine can be synthesized *de novo* from glucose *via* the TCA intermediate α-ketoglutarate (αKG) and L-glutamate. mESCs grown in the presence of serum and LIF plus exogenously added L-glutamine proliferate rapidly: The L-glutamine provides a source of precursors for protein, purine and pyrimidine synthesis required for rapid cell division, and feeds back into the TCA cycle *via* L-glutamate and αKG to maintain anaplerosis. However, as with many types of mammalian cell, removal of exogenous L-glutamine from the medium of mESCs halts proliferation ([@ref38]); that is, this amino acid is conditionally required as it cannot be synthesized in sufficient quantity *de novo* to meet mESCs' proliferative capacity.

Removal of L-glutamine also results in the downregulation of expression of a number of pluripotency factors such *Oct4, Rex1,* and *Nanog* and the upregulation of expression of trophectoderm and mesoderm markers. Conversely, the presence of L-glutamine inhibits differentiation and promotes mESC self-renewal and pluripotency ([@ref214]).

These cellular responses to L-glutamine depend on its ability to rapidly upregulate the PI3K/Akt pathway, which, *via* PKC and ERK, stimulates the mTORC1 pathway ([@ref214]). Collectively, the flux through these pathways (1) maintains self-renewal and pluripotency by enhancing the expression of pluripotency markers, (2) stimulates proliferation through upregulation of the expression of cell-cycle proteins, (3) enhances acetylation at specific marks on Histone 3 by inhibiting the expression of the histone deacetylase HDAC1, and (4) results in hypomethylation of DNA through inhibition of DNA methyltransferases Dnmt3a and Dnmt3b. In particular, these histone and DNA modifications occur at the *Oct4* gene, resulting in enhanced expression of Oct4 and therefore increased activity of the core pluripotency network ([@ref214]).

These effects by L-glutamine first depend on its conversion to L-glutamate, as inhibition of glutaminase, which converts L-glutamine to L-glutamate, blocks the effects ([@ref214]). L-glutamate can then be converted to the TCA-cycle intermediate αKG, thereby maintaining a high αKG-to-succinate ratio. A high ratio upregulates the activity of both Jumonji C-domain-containing histone demethylases and Tet family DNA demethylases. The extent and specificity of epigenetic modification *via* these demethylation mechanisms presumably complement those L-glutamine-regulated mechanisms (described above) involving increased histone acetylation and DNA hypomethylation ([@ref214]). The result is a complex epigenetic landscape which allows mESCs to self-renew but poises the cells for rapid differentiation should the correct signals become available.

Details of the role of the mTORC1 pathway in maintaining this L-glutamine-mediated mESC identity, presumably *via* its control of CAP-dependent and independent mRNA translation, remains poorly understood at this stage.

### L-Threonine/L-Methionine Acts as a Survival and Self-Renewal Factor for ESCs {#sec24}

Like L-glutamine, the restriction of L-threonine in the culture medium of mESCs results in greatly reduced proliferation, reduced expression of many self-renewal markers and increased expression of trophectoderm and mesoderm markers. The addition of L-threonine reverses these effects ([@ref213]).

Although ESCs are metabolically fairly quiet, their rapid proliferation requires bases for DNA synthesis. Partly to satisfy this demand, mESCs have a "high-flux backbone" of metabolic activity involving threonine dehydrogenase (TdH), whose activity is 200--1,000× higher than many other cells and tissues and which is rapidly downregulated upon mESC differentiation ([@ref272], [@ref271]; [@ref226]) Amongst other things, this backbone supplies metabolites that can be used in purine biosynthesis necessary for cell-cycle progression ([@ref272]).

A second consequence of this highly active metabolic circuitry is the maintenance of a high ratio of *S*-adenosylmethionine to *S*-adenosylhomocysteine (SAM/SAH). SAM is the universal substrate for protein methyltransferases, including histone methyltransferases, and these reactions are product-inhibited by SAH. The high SAM/SAH ratio results in maintenance of H3K4me3 ([@ref226]), a permissive expression mark critical for mESC self-renewal ([@ref20]; [@ref5]; [@ref226]). Other H3 lysine methylation marks are not sensitive to the presence or absence of L-threonine ([@ref226]). This selectivity is due in part to the Trithorax group of proteins, which complexes with histone methyltransferases that methylate H3K4. In particular, the Trithorax group component Wdr5 binds to Oct4, thereby helping to target H3K4 trimethylation and upregulates expression of genes in the core and the extended pluripotency networks ([@ref20]; [@ref5]).

As with L-glutamine, L-threonine rapidly activates a range of signaling pathways: ERK, p38, JNK/SAPK and the mTORC pathways all appear to be activated following initial activation of PI3K/Akt. Inhibition of these cooperating pathways (e.g., by the use of wortmannin to inhibit PI3K/Akt or rapamycin to inhibit mTORC1) prevents L-threonine-induced maintenance of self-renewal and proliferation ([@ref213]).

In humans, *TdH* is expressed as a nonfunctional pseudogene and hESCs cannot rely on maintaining SAM/SAH ratios *via* L-threonine metabolism. Instead, they strongly upregulate flux through the L-methionine cycle, which lies downstream of TdH, and in which the conversion of L-methionine to SAM is catalyzed by methionine adenosyltransferases ([@ref224]).

### L-Proline Stimulates Differentiation of mESCs to EPL Cells {#sec25}

The delicate balance of LIF-mediated pathway activities which maintains mESC self-renewal (Section "LIF-Mediated Signaling and the Control of mESC Self-Renewal") is tipped by culturing mESCs in the presence of MEDII, a conditioned medium derived from the human hepatocarcinoma cell line, HEPG2 ([@ref204]). Fractionation of MEDII revealed the non-essential amino acid L-proline as a bioactive molecule involved in this differentiation process ([@ref204]; [@ref274]). The concentration of L-proline contained in MEDII (\~150 μM) is similar to that found in murine tubal fluid ([@ref274]; [@ref116]). mESCs cultured in MEDII produce a homogenous population of EPL cells that are phenotypically and genetically distinguishable from mESCs ([@ref204]; [@ref274]). EPL cells have downregulated expression of the ESC markers *Nanog* and *Rex1.* The expression of the primitive ectoderm marker *Fgf5* is upregulated as is that of *Dnmt3b,* while the expression of the pluripotency marker *Oct4* is maintained ([Table 1](#tab1){ref-type="table"}; [@ref92]).

###### 

Comparison of mouse embryonic stem cells (mESCs) with early primitive ectoderm-like (EPL) cells.

                                                mESCs                                           EPL cells                                                                   References
  --------------------------------------------- ----------------------------------------------- --------------------------------------------------------------------------- ---------------------------------------------
  *In vivo* equivalent                          Inner cell mass                                 Primitive ectoderm                                                          ([@ref204]; [@ref274]; [@ref40])
  Potency                                       Pluripotent                                     Pluripotent                                                                 ([@ref204]; [@ref274]; [@ref40])
  Lineage contribution                          Primitive ectoderm, Primitive endoderm          Definitive endoderm, Definitive mesoderm, Definitive ectoderm, Germ cells   ([@ref144]; [@ref370])
  Chimera formation?                            Yes                                             No                                                                          ([@ref204])
  Gene and protein expression                   *Oct4*                                          *Oct4*                                                                      ([@ref204]; [@ref188]; [@ref92]; [@ref274])
  *Sox2*                                        *Sox2*                                                                                                                      
  *Nanog*                                       *Nanog*                                                                                                                     
  Alkaline phosphatase                          Alkaline phosphatase                                                                                                        
  *Rex1* [*^\*^*](#tfn1){ref-type="table-fn"}   *Fgf5* [*^\*^*](#tfn1){ref-type="table-fn"}                                                                                 
  *Psc1*                                        *Dnmt3b* [*^\*^*](#tfn1){ref-type="table-fn"}                                                                               
  *Crtr1*                                                                                                                                                                   
  Colony phenotype                              Round, dome shaped, defined colony borders      Flat, epithelial, visible individual cells                                  ([@ref204]; [@ref274])
  Cell-cycle time                               \~12 h                                          \~8 h                                                                       ([@ref33]; [@ref49]; [@ref277]; [@ref182])

denotes marker expression.

The exogenous addition of L-proline to mESCs ([@ref146]; [@ref274]; [@ref40]; [@ref251]) tips the balance from self-renewal to differentiation, resulting in the production of EPL cells. L-proline effects change in a wide range of emergent properties in ESCs including an EMT, apoptosis, increased proliferation, as well as differentiation. Again, a large number of interconnected mechanisms are involved, consistent with the response of a complex system. These include cell signaling, proline metabolism, autophagy, and changes in gene expression and the epigenetic landscape ([@ref146]; [@ref274]; [@ref40]; [@ref252], [@ref251]; [@ref51]; [@ref54]).

L-proline enters mESCs *via* the SNAT2 transporter ([@ref274]; [@ref252]). There is prompt activation of the amino-acid sensing mTORC1 signaling pathway ([@ref274]; [@ref252]), the differentiation-inducing MEK/ERK pathway ([@ref146]), and p38 pathway ([Figure 7](#fig7){ref-type="fig"}; [@ref251]). Inhibitors of each pathway prevent EPL-cell formation, indicating each is necessary but not sufficient for differentiation ([@ref146]; [@ref274]; [@ref252], [@ref251]; [@ref93]). L-leucine and glycine activate mTORC1 signaling but fail to induce the transition, also indicating this pathway is not sufficient for the transition ([@ref274]). The fact that many of these pathways also respond to L-glutamine and L-threonine, with the result that mESC self-renewal is maintained rather than differentiation induced, is again indicative of the delicately poised state of these cells between very different fates.

mTORC1 activity is known to regulate the activity of proteins involved in cell cycle progression such as c-Myc and cyclin-D ([@ref158]). This is consistent with the increased cell numbers observed upon the addition of L-proline to ESCs and the reduction in numbers when the mTORC1 inhibitor, rapamycin, is added ([@ref274]; [@ref252]).

During early embryonic development, the importance of mTOR signaling is shown by *mTOR*^−/−^ mouse embryos in which the ICM and trophectoderm exhibit reduced proliferation and differentiation, and embryonic lethality just prior to implantation ([@ref70]; [@ref168]). The mechanisms have not been elucidated but the results from ESCs are likely to provide important leads.

L-proline triggers changes to the epigenetic landscape of ESCs, which are required for the EMT ([@ref51]). In particular, L-proline enhances methylation at H3K9 and H3K36. On the other hand, vitamin C, a cofactor for Jumonji domain demethylases, reduces methylation at H3K9 and H3K36 and results in a mesenchymal-to-epithelial transition ([@ref51]).

As with L-threonine and L-glutamine, the effect of L-proline on mESCs depends, in part, on its metabolism and intracellular concentration. Due to its pyrrolidine ring, L-proline has a unique metabolism, *via* the proline cycle, which appears to contribute to differentiation ([@ref40]). In addition, mESCs limit their intracellular concentration of L-proline to about one quarter of that found in EPL cells and one tenth that found in mouse embryonic fibroblasts ([@ref54]). This self-limiting production is sufficient to allow mESC survival while maintaining mESC identity and proliferation rate but is insufficient to promote the EMT and differentiation ([@ref54]).

The balance between these very different fates is controlled in part by an autoregulatory loop mediated by the Gcn2-Eif2α-Atf4 axis and its control of the amino-acid starvation response (AAR) pathway ([Figure 9](#fig9){ref-type="fig"}; [@ref89]; [@ref54]). In the proline-starved state, free prolyl-tRNA (i.e., not loaded with proline) binds Gcn2, which upregulates AAR pathway activity including expression of genes in, for example, transport and synthesis of amino acids. In particular, the transcription factor Atf4 selectively upregulates the expression of the enzymes responsible for the production of L-proline from L-glutamate ([Figure 9](#fig9){ref-type="fig"}). There is also, however, a concomitant general suppressing effect on translation, consistent with the conservation of energy in a low-nutrient environment. Negative feedback occurs when the L-proline that is endogenously produced reduces the pool of free prolyl-tRNA ([@ref54]).

![Model of L-proline-mediated differentiation of mESCs to EPL cells. L-Pro enters the cell *via* the SNAT2 transporter ([@ref252]) where it **(A)** acts on various signaling pathways including the amino acid-sensing signaling mTOR pathway, ERK and P38 pathways to induce differentiation ([@ref146]; [@ref274]; [@ref251]). **(B)** L-Pro is metabolized to pyrroline-5-carboxylate (P5C) by proline oxidase (POX) *via* the proline cycle in the mitochondria. P5C can then be converted to glutamate (Glu) by P5C dehydrogenase (P5CD). Glu is further converted to alpha-ketoglutarate, which enters the TCA cycle with subsequent production of ATP *via* oxidative phosphorylation (OxPhos). Glu can also be converted to L-Pro *via* the sequential actions of P5C synthase (P5CS) and P5C reductase (P5CR). This conversion produces NADP^+^, which is required to stimulate the pentose phosphate pathway (PPP) in the cytoplasm of the cell ([@ref184]; [@ref193]). The PPP is required to generate the ribose components needed for DNA and RNA synthesis and is coupled with aerobic glycolysis to generate ATP in highly proliferative cells such as ESCs and cancer cells ([@ref811]). Stimulation of the PPP and glycolysis in the presence of L-Pro ([@ref811]) may stimulate the differentiation of mESCs to EPL cells and support the increased proliferation rates observed in EPL cells. **(C)** When mESCs are starved of L-Pro, the amino acid response (AAR) pathway is activated to control L-Pro production and uptake into the cell. Free prolyl-tRNA (i.e., not loaded with L-Pro) binds to General Control Non-Depressible-2 (Gcn2) kinase which phosphorylates Eukaryotic Initiation Factor-2 (eIF2), resulting in Activating Transcription Factor-4 (Atf4) regulating the expression of genes involved in L-Pro transport and metabolism. The net result of this autoregulatory loop is self-limiting concentrations of L-Pro resulting in mESC self-renewal ([@ref54]). When L-Pro is added exogenously, this pathway is overwhelmed triggering differentiation.](fphys-10-00705-g009){#fig9}

When L-proline is added exogenously, this autoregulation is overwhelmed: The AAR pathway shuts down and its generalized suppression of translation is lifted allowing L-proline-mediated differentiation, EMT, and reduced cell cycle time leading to increased proliferation ([@ref54]). The relief of translation suppression is probably also mediated by L-proline-mediated upregulation of the mTORC1 pathway ([@ref274]) which controls CAP-dependent and CAP-independent translation.

mESCs are also in relative torpor with respect to translation given that ribosomal machinery is abundantly available but poorly loaded with mRNA ([@ref216]). It is not known to what extent, if at all, the addition of L-proline awakens mESCs from this form of torpor by facilitating ribosomal loading.

These data contribute to a rapidly evolving paradigm across various fields of cell biology: that changes in metabolism are not merely passengers to differentiation but drivers of it. L-proline-mediated differentiation of ESCs appears to be the first example of an amino acid effecting metabolism-based differentiation. In particular, mESCs appear primed to meet the metabolic load required for differentiation but will not do so until selected nutrients are available. Exogenous sources of L-proline may provide the key to unlocking this machinery within the embryo to allow normal development to proceed.

L-Proline-Mediated Neurectoderm Induction {#sec26}
-----------------------------------------

mESCs cultured in the conditioned medium MEDII undergo differentiation through EPL cells, definitive ectoderm and neurectoderm, followed by mature neuronal differentiation to a naïve midbrain population of cells in the presence of serum-free (F12:DMEM) medium ([@ref203]; [@ref205]; [@ref92]). mESCs cultured under these conditions therefore recapitulate early embryonic neural development ([@ref203]).

Similar results are seen when mESCs are cultured as EBs in the presence of L-proline ([@ref225]). Perhaps significantly, L-proline is also present in F12 (0.3 mM), which is commonly incorporated into neural differentiation protocols ([@ref10]; [@ref147]; [@ref92]). Given the role that L-proline plays in the transition of mESCs to EPL cells at a cell signaling, metabolic, and epigenetic level, L-proline may play a similar complex role in controlling the emergent properties required for neural-lineage commitment from the EPL-cell stage. Understanding these complex mechanisms will have at least two advantages: (1) It will allow us to gain a better appreciation of the important role amino acids play during early embryonic development, and (2) allow us to better devise protocols for neural-cell production in order to gain further understanding of how the nervous system develops at a molecular level.

Limitations in the Use of Pluripotent Cells {#sec27}
-------------------------------------------

While pluripotent cells have proven to be an exceptionally informative *in vitro* model for understanding the molecular mechanisms and complexity of development they do, as with any model system, have limitations. The reductive experimental approaches required, such as the limited selection and addition/removal of apparent master regulators to the culture medium to promote lineage-directed differentiation, grossly simplifies the systems biology occurring *in vivo*, which depends on both the complex and ever-changing maternal environment and internal environment of the embryo itself. In particular, in the self-organizing system of development, subtle and highly nonlinear interactions between large numbers of components are the norm, and it becomes difficult---or impossible---using a simplified *in vitro* model to tease these out ([@ref14]; [@ref198]).

While a very large number of protocols exist for the lineage-directed differentiation of pluripotent cells, few conform well to the timing observed for the equivalent events occurring *in vivo*. To what extent this interferes with the ontogenetic progression of these cultured cells compared to those *in vivo* remains very poorly studied. An exception, at least in terms of timing of ontogenetic progression, appears to be the MEDII ([@ref204]; [@ref274]) and L-proline-mediated ([@ref225]) differentiation protocols for differentiating mESCs to neurectoderm and on to mature neural cell types. An additional advantage with these protocols appears to be the relatively synchronous/homogeneous progression through the embryonically equivalent intermediate stages of naïve mESCs to EPL cells to definitive ectoderm to neurectoderm, which allows ready isolation and analysis of these intermediate stages with little or no further cell manipulation. Protocols which generate neurectoderm more quickly exist (e.g., [@ref292]) but this appears to be accompanied by reduced synchronous/homogeneous progression, makes it difficult to pinpoint the best times to isolate the intermediate cell types, and is accompanied by considerable cell death as the cells differentiate through a crisis point. The issue of purity of isolated cell types remains a demanding one in the field particularly where whole-population analysis is used with methods such as qPCR, kinome arrays, and whole-transcriptome studies using, for example, RNAseq.

Despite these and related issues, analysis of cultured pluripotent cells remains a pre-eminent approach to understanding the molecular mechanisms underpinning development.
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